The Science Behind Early Detection
Pancreatic cancer is one of the most difficult cancers to detect early, and that gap between diagnosis and treatment is where lives are lost. This page explains the science driving our work and why artificial intelligence represents a genuine breakthrough in changing those odds.
The Problem
Why Pancreatic Cancer is so Hard to Catch
Pancreatic cancer is often called a “silent disease.” It produces few symptoms in its early stages, and those it does produce, including fatigue, mild abdominal discomfort, changes in digestion, are easy to miss or attribute to other causes. By the time symptoms become noticeable, the disease has frequently spread beyond the pancreas.
Surgery is the only curative treatment, but this is only possible when the cancer is localized, when it has not yet spread to surrounding tissue or distant organs. Approximately 85% of patients are diagnosed after the cancer has already metastasized, placing them beyond the reach of surgery and significantly limiting treatment options.
Current imaging methods have not kept pace with the challenge. Standard CT imaging misses a significant proportion of small tumors, the very ones that could still be surgically removed if caught. The window for intervention is narrow, and traditional tools are not reliably finding tumors within it.
The Opportunity
AI-Driven Detection
Artificial intelligence does not replace radiologists, it makes them more powerful. AI systems trained on large datasets of pancreatic imaging can identify subtle patterns in CT scans that are difficult for the human eye to detect consistently, particularly in early-stage tumors where size and contrast are minimal.
The application of AI to pancreatic imaging is designed to do two things: increase the sensitivity of detection to catch more tumors at earlier stages, and reduce the rate of false negatives and missed diagnoses. Together, these improvements shift the moment of diagnosis earlier in the disease’s progression, which is precisely when intervention is most effective.
Research supported by the Foundation is advancing AI models capable of analyzing CT scans with greater precision, helping radiologists identify suspicious findings that warrant further evaluation.
Why This Matters
The Survival Gap
The five-year survival rate for pancreatic cancer diagnosed at a localized stage, before cancer spreads, is approximately 40-45%. For cancer diagnosed after it has spread to distant organs, that figure drops to around 3%. The difference between those two numbers is, in large part, a matter of when the cancer is found.
The David M. Blank Foundation exists because this gap is closable. AI-driven detection is a concrete, achievable advance in how we screen for and identify this disease.